相关实验视频
Updated: Sep 10, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
1.0K
在创伤中使用特兰克萨姆酸
Whitney J Barrett1, Kevin A Kaucher2, Ross E Orpet3
1Department of Emergency Medicine, University of New Mexico School of Medicine, Albuquerque, NM, National Association of EMS Physicians.
Annals of emergency medicine
|August 22, 2025
概括
在医院前创伤护理中使用特兰克萨姆酸 (TXA) 是有争议的. 新证据支持紧急医疗服务 (EMS) 关于给受伤患者静脉注射TXA的最新指南.
科学领域:
- 紧急医疗
- 创伤护理
- 药理学
背景情况:
- 在过去的十年中,医院前使用酸 (TXA) 显著增加.
- 关于在创伤患者中广泛使用TXA的益处存在矛盾的证据.
- 此前关于医院前TXA的指导在2016年发布.
研究的目的:
- 提供最新的,基于证据的建议,用于在受伤患者的静脉注射TXA.
- 解决有关TXA在紧急医疗服务 (EMS) 的不断变化的研究环境.
主要方法:
- 进行了结构化的文献审查,以综合最近的研究结果.
- 根据附带资源文件中总结的证据制定了建议.
主要成果:
- 审查发现了在医院前TXA给药后患者的结果的新研究.
- 这些发现为制定最新的临床指南提供了信息.
结论:
- 美国急诊医生协会,美国外科医生协会创伤委员会和美国急诊医生协会提供了最新的建议.
- 这些建议指导了在受伤患者的医院前适当使用静脉TXA.
相关概念视频
Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
Introduction to Hemostasis
8.9K
Hemostasis is a complex physiological process that prevents excessive bleeding when a blood vessel is injured. It's crucial for maintaining the integrity of the circulatory system, as it ensures that our blood remains fluid while still within the vascular network and yet clots to prevent blood loss upon vessel injury.
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
8.9K
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
Vascular Spasm
1.8K
The vascular phase, also known as vasospasm, is the initial stage of hemostasis, crucial for preventing excessive bleeding when a blood vessel is injured. After a vessel is cut, nerves in the damaged area trigger pain and other sensory impulses. Simultaneously, the smooth muscles in the vessel wall contract, resulting in a vascular spasm. This contraction reduces the vessel's diameter at the injury site, slowing or stopping blood loss through the vessel wall. Vascular spasms typically last...
1.8K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K

